Creative Planning Takes Position in Invesco Dynamic Pharmaceuticals ETF (PJP)

Creative Planning bought a new position in Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP) during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 3,420 shares of the company’s stock, valued at approximately $223,000.

Several other institutional investors have also recently added to or reduced their stakes in PJP. Morgan Stanley grew its position in Invesco Dynamic Pharmaceuticals ETF by 33.8% during the third quarter. Morgan Stanley now owns 103,448 shares of the company’s stock valued at $7,605,000 after purchasing an additional 26,142 shares in the last quarter. Reilly Financial Advisors LLC grew its position in Invesco Dynamic Pharmaceuticals ETF by 7.1% during the fourth quarter. Reilly Financial Advisors LLC now owns 27,720 shares of the company’s stock valued at $1,728,000 after purchasing an additional 1,830 shares in the last quarter. LPL Financial LLC grew its position in Invesco Dynamic Pharmaceuticals ETF by 1.8% during the fourth quarter. LPL Financial LLC now owns 97,245 shares of the company’s stock valued at $6,063,000 after purchasing an additional 1,706 shares in the last quarter. Institute for Wealth Management LLC. purchased a new position in Invesco Dynamic Pharmaceuticals ETF during the fourth quarter valued at approximately $686,000. Finally, Raymond James Financial Services Advisors Inc. grew its position in Invesco Dynamic Pharmaceuticals ETF by 2.7% during the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 7,858 shares of the company’s stock valued at $490,000 after purchasing an additional 209 shares in the last quarter.

Shares of PJP opened at $60.64 on Tuesday. Invesco Dynamic Pharmaceuticals ETF has a 52 week low of $58.29 and a 52 week high of $74.29.

COPYRIGHT VIOLATION WARNING: This piece of content was reported by Dakota Financial News and is the property of of Dakota Financial News. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://dakotafinancialnews.com/2019/05/14/creative-planning-takes-position-in-invesco-dynamic-pharmaceuticals-etf-pjp.html.



Invesco Dynamic Pharmaceuticals ETF Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.

Read More: Index Funds

Want to see what other hedge funds are holding PJP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP).

Institutional Ownership by Quarter for Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP)

Receive News & Ratings for Invesco Dynamic Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Dynamic Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.